Topic:Antitoxin
Antitoxins in horses are antibodies that neutralize toxins produced by infectious agents. They are integral to the horse's immune response, providing passive immunity against specific toxins. Antitoxins can be naturally produced by the horse's immune system following exposure to a toxin or administered through therapeutic preparations to counteract toxin effects. Commonly used antitoxins in equine medicine include those targeting tetanus and botulism toxins. The administration of antitoxins can be a preventive measure or a treatment strategy during toxin exposure. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, applications, and efficacy of antitoxins in equine health management.
Toxigenic characteristics of Clostridium perfringens type C in enterotoxemia of domestic animals. Eleven Clostridium perfringens type C strains isolated from fatal cases of hemorrhagic enterotoxemia of Canadian calves, a piglet, and a foal were studied for the production of soluble antigens. All the isolates from calves and a foal failed to produce delta toxin, but were capable of producing large amounts of lethal beta toxin. A strain isolated from a piglet produced delta, but very little beta toxin. Other differences were relatively minor. The results indicated that young domestic animals may be susceptible to all subtypes of C. perfringens type C. A simple method of using blood agar plat...
[Development of autoimmune reactions in horses serving to produce antitetanus serum]. The hyperimmunization of horses with large doses of tetanus toxoid is accompanied by an increase in the levels of both specific antitoxic antibodies and autoantibodies to the tissue antigens of the liver, the spleen, the heart. The reverse relationship between the level of autoantibodies and the titer of antitoxin has been established. The authors suggest that the synthesis of autoantibodies is stimulated by the presence of antigen-antibody immune complexes in the circulating blood, as well as by the action of exo- and endopolyclonal stimulators.
Anti-lipopolysaccharide toxin therapy for whole body X-irradiation overdose. Death in humans from ionising radiation overexposure in the 3-8 Gy (300-800 rad) range is in part due to the toxaemia caused by the entry of gram-negative bacteria and/or their lipopolysaccharide toxin (LPS) into the blood circulation through the walls of partially denuded gut. Anti-LPS hyperimmune equine plasma was evaluated for its ability to lower irradiation-induced lethality. Mice were irradiated with 6.3 Gy (630 rad) and six days later received equine Anti-LPS hyperimmune plasma, control plasma or saline. Mortalities in the three groups were 58%, 92% and 79% (p less than 0.01) respective...
Antibody to equi factor(s) in the diagnosis of Corynebacterium equi pneumonia of foals. Antibody to equi factor(s) in cases of Corynebacterium equi pneumonia in foals was detected using C. pseudotuberculosis exotoxin sensitized calf red blood cells. The test was standardized using antitoxin produced in rabbits by injection of equi factor(s). All sera from ten foals with culture-diagnosed C. equi pneumonia had antibodies to equi factor(s) (titre range 8-256, mean 74.0) and nine sera from 11 foals with suspected C. equi pneumonia also showed antibodies (titre range 4-512, mean 136.4). Two of five pneumonia foals with transtracheal aspirate cultures not yielding C. equi had such ant...
Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. Serum levels of equine-botulism antitoxin to toxin types A, B, and E were measured in four type-A botulism patients who had received equine-botulism antitoxin. High circulating levels capable of neutralizing in excess of 1 X 10(8), 9 X 10(7), and 6 X 10(6) 50% mouse lethal doses of toxin of types A, B, and E, respectively, were detected. There was little depletion of type-A antitoxin even though two of the patients had circulating type-A toxin before treatment. The half-life for antitoxin persistence for one patient was calculated as being 6.5, 7.6, and 5.3 days for antitoxin types A, B, and E...
Duration of maternally derived immunity to tetanus and response in newborn foals given tetanus antitoxin. Serum tetanus antitoxin (TAT) concentrations were measured in a group of 30 foals from birth to 4 months of age. Five of 30 foals (16.6%) had serum titers less than 0.01 IU of TAT/ml by 1 month of age. At 2 months of age, 17 of 28 foals (60.7%) had titers less than 0.01 IU/ml. By 3 months of age, 22 of 29 (75.5%) foals tested had titers of less than 0.01 IU/ml. At the age of 4 months, 24 of 29 foals (82.1%) had titers of less than 0.01 IU/ml. The TAT given to foals at birth resulted in an immediate increase in titer when circulating antitoxin was absent or minimal. Titers considered protective...
Enhancement of Naja naja atra antivenin production in horses. As the conventional hyperimmunization schedule in horses introduced by Tanaka could not produce enough neutralizing antibody against Naja naja atra venom, the mixture of Carboxymethyl cellulose (CMC)-Cobra venom incorporated with adjuvant was used for immunization. The neutralizing antibody produced (30 LD50) seemed to be increased but still not to reach the satisfactory level. By using CMC-Cobratoxin adjuvant mixture as an immunizing agent, highly potent antivenin (220 LD50) was obtained.
Active immunisation of horses against tetanus including the booster dose and its application. Successful active immunisation of horses against tetanus is dependent on a number of factors of which the toxoid preparation used, its method of application and the ability of the individual horse to respond are fundamental. Two immunisation schedules using an aluminium-based toxoid preparation were examined and the protection determined by monitoring the level of antitoxin afforded by each schedule. The results obtained demonstrated that 2 doses of this toxoid are necessary to ensure 12 months protection in all horses. These results are discussed in relation to the factors involved in active ...
A negative serological relationship between cases of grass sickness in Scotland and Clostridium perfringens type A enterotoxin. In an attempt to compare the equine grass sickness as reported in Europe with that described in the Republic of Colombia, sera from horses experiencing grass sickness in Scotland were used in neutralisation tests with Clostridium perfringens type A enterotoxin. The sera, from acute and chronic cases of the disease, failed to neutralise either crude or partially-purified enterotoxin. Neither were precipitin lines formed when the sera were treated against the toxin in immunoelectrophoresis. These results suggest that grass sickness in Europe and the equine disease in Colombia have a different ae...
Combined active-passive immunisation of horses against tetanus. The protection afforded by active, passive and combined active-passive methods of immunisation against tetanus was examined in previously unimmunised horses. Three groups of horses were injected; one with tetanus toxoid alone, one with tetanus antitoxin alone and one in which the tetanus toxoid and tetanus antitoxin were injected simultaneously. The protection afforded was determined by monitoring the levels of antitoxin achieved in the horses by each of these methods. The results obtained demonstrated the effectiveness of the combined active-passive method in affording rapid and prolonged pro...
Dynamic changes of horse serum T-globulin immunization with snake venoms, tetanus and diphtheria toxoids. In course of immunizing horses with snake venoms, tetanus and diphtheria toxoids, a new serum component, T-globulin, was formed and migrated between the beta- and gamma-globulins. The T-globulin content was parallel with the antibody titre after the middle course of immunization. There were many components in snake antivenin and T-globulin was composed of most of those components. The components of diphtheria T-globulin were the same as those of crude antitoxin and tetanus T-globulin except one precipitin.
The immune response of horses to tetanus toxoid. An intramuscular injection of 8-16 Lf tetanus toxoid in water-in-oil emulsion protected adult horses against tetanus for at least 128 weeks. A booster dose of 8 Lf toxoid in aqueous solution protected them for a further period of at least 3 1/2 years. Colostral immunity protected foals for at least 10 weeks. An intramuscular injection of 8 Lf toxoid in water-in-oil emulsion given to foals from immune dams when they were 10-18 weeks old did not elicit any antibody response. They did respond, however, to a booster injection of 8 Lf toxoid in aqueous solution given 12 weeks after the first dose. ...
Isolation and characterization of antibodies to Clostridium perfringens epsilon toxin from hyperimmune horse serum. Antibodies against epsilon toxin were isolated from hyperimmune horse serum by affinity chromatography. Purified epsilon prototoxin covalently bound to Affigel 202 was used as immunosorbent, and antibodies were eluted with 6.0 M guanidine chloride. In a single run 80 mg of antibody could be recovered from a 20 microliter column of immunosorbent. The antibody was shown to belong to the IgG(T) class of immunoglobulins.
Stability of the lyophilized F(ab’)2 fragments of horse tetanus antibodies isolated by affinity chromatography. F(ab')2 fragments of horse tetanus antibodies were obtained from horse hyperimmune sera after peptic digestion. The digest was passed through a column of tetanus toxoid coupled with Sepharose 4B, F(ab')2 fragments were eluted with a solution of 5 mM HCl in 150 mM NaCl and the eluates were concentrated by ultrafiltration and lyophilized. Glycine and human serum albumin were used as stabilizing agents. Polyacrylamide gel electrophoretic mobility and molecular weight of the fragments remained unchanged after lyophilization. Freeze-dried preparations stored two months at 56 degrees C showed only a...
Equine grass sickness: serologic evidence of association with Clostridium perfringens type A enterotoxin. Clostridium perfringens type A enterotoxin seroneutralization was carried out on sera from 50 horses recovered from grass sickness and from 100 other horses with no record of having had the disease. Of the affected horses, 70% had seroneutralizating titers higher than 1:64, half of these being equal or higher than 1:128. More than 88% of the horses with no record of grass sickness had titers lower than 1:64. These data support the theory of association between C perfringens type A toxins and grass sickness.
Serum antibody to Escherichia coli heat-labile enterotoxin in cattle and swine. Antibody titers to Escherichia coli heat-labile enterotoxin (LT) were measured in serum samples collected from mature cows, butcher pigs, mature sows and adult sheep, horses, dogs, cats, turkeys, and chickens. The frequency of LT antitoxin titers was greatest in sows (94%) and less in cows (38%). Titers were higher in swine than in cattle. There were no LT antitoxin titers in serums from sheep, horses, dogs, cats, turkeys, and chickens. It was concluded that LT-producing Escherichia coli are prevalent in the swine population, but much less so in cattle and the other species examined.
Treatment of tetanus in the horse by injections of tetanus antitoxin into the subarachnoid space. In 40 horses with tetanus, large doses of tetanus antitoxin (TAT) were injected into the subarachnoid space. In all the horses that recovered, the disease stabilized immediately after the injection. The results (77.5% recovery) were much better than in a previous series of horses with tetanus (50% recovery), in which TAT was injected either intravenously, intramuscularly, or in the epidural space.
[Prevention of tetanus in man and animal following injury]. The effect of heterologous and homologous antitoxin is the same if an equal amount of antitoxin is present in the organism. In man there are no circulating antibodies in the blood after the first injection of the toxoid because there is no natural immunity against the tetanus antigen. After the second injection, man develops the same immunity as animals. Large antitoxin doses protect people for a longer period than small doses. Normally 3,000 I. U. of the heterologous antitoxin protects people for 2 to 3 weeks. In man and sheep 2 ml of the adsorbed vaccine produces an earlier and longer-lastin...
Snakebite in the horse. Four cases of snakebite in horses are presented. Diagnosis was made on clinical signs in all, plus fang punctures in 2 cases. Tiger snake antivenene was used in the treatment of 2 patients and these recovered rapidly. Of the 2 in which antivenene was not used, 1 severely affected horse died. The clinical signs which were observed were those of progressive general paralysis and were entirely referable to the neurotoxic component of the venom.